2−, are claimed. The freebase has an individual tryptamine mol­ecule within the asymmetric device. The mol­ecules are linked jointly by N—H?N hydrogen bonds in zigzag chains along the [010] course. The compound has potential as being a therapeutic as it has a quick onset and f